A 73-year-old woman with metastatic breast cancer took high doses of ivermectin after reading about it online, had seizures and stopped breathing adequately, and spent two days on a ventilator before recovering fully.
The patient self-administered high doses of ivermectin based on information obtained online, developed acute altered mental status, generalised seizures and respiratory failure, and was managed with intubation, mechanical ventilation, intravenous fluids and anticonvulsants, recovering to baseline within 48 hours (Saperstein case report 2026). The authors note that the FDA has explicitly discouraged ivermectin for cancer outside clinical trials and ask clinicians to take a thorough exposure history (Saperstein case report 2026).
The clearest documented case of what the label's neurotoxicity warning looks like in a cancer patient dosing herself.
Shares Off-label, Ivermectin, Misinformation and unproven therapies.
Shares Off-label, Ivermectin, Misinformation and unproven therapies.
Shares Off-label, Ivermectin, Misinformation and unproven therapies.